Business Context and Reporting Period
This Form 6-K filing by MediWound Ltd. covers the extraordinary general meeting of shareholders held on January 28, 2016. The report details the voting outcomes for three proposals previously outlined in the proxy statement filed on December 23, 2015.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document focuses exclusively on corporate governance and shareholder voting results rather than financial performance.
Material Changes and Voting Results
- Shareholder Participation: As of the record date (December 30, 2015), there were 21,850,300 ordinary shares issued and outstanding.
- Attendance: 12,204,659 shares were present in person or by proxy, representing 55.86% of outstanding shares.
- Quorum: A quorum was properly convened under the Company's Articles of Association.
- Outcome: All three proposals voted upon at the meeting were approved based on the majority requirements of the Israeli Companies Law and the Company's Articles of Association.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on financial outlook, specific risks, contingencies, or unusual items. The document serves as a formal record of the shareholder meeting's conclusion.
Investor Verification Checklist
- Verify the specific details of the three approved proposals in the proxy statement filed on December 23, 2015 (Exhibit 99.1).
- Confirm the impact of the approved proposals on the Company's capital structure or operations.
- Review the Registration Statements on Form S-8 (No. 333-195517) and Form F-3 (No. 333-209106) into which this report is incorporated by reference.